trending Market Intelligence /marketintelligence/en/news-insights/trending/SMlyVR0BYcVHXPkvqZTgJQ2 content esgSubNav
In This List

Pacira BioSciences to join S&P SmallCap 600 index

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Pacira BioSciences to join S&P SmallCap 600 index

Pacira BioSciences Inc. will join the S&P SmallCap 600 index, replacing digital imaging company Shutterfly Inc., effective before trading opens Sept. 30.

Parsippany, N.J.-based Pacira BioSciences develops non-opioid pain management therapies in the U.S. The company will join the S&P SmallCap 600 Global Industry Classification Standard Pharmaceuticals Sub-Industry index.

Shutterfly is being acquired by private equity firm Apollo Global Management Inc. in a deal valued at $2.7 billion.

S&P Dow Jones Indices and S&P Global Market Intelligence are owned by S&P Global Inc.